Alzheimer's disease [Болезнь Альцгеймера]
Коберскайа Н. Н.
Неврология, нейропсихиатрия, психосоматика
Т. 11, С. 52-60
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.14412/2074-2711-2019-3S-52-60
Аннотация:
Despite progress made in laboratory methods, genetic studies, and modern neuroimaging, the diagnosis of diseases that cause dementia makes difficulties. The review presents an update on the epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis, and treatment of Alzheimer's disease (AD). It discusses the issues of symptomatic and pathogenetic treatments and combination therapy for AD. The efficacy of memantine (akatinol memantine) and the expediency of its use at different stages of the disease in patients with AD are noted. Non-pharmacological treatments for this disease, including physical activity and cognitive training, are considered. © 2019 Ima-Press Publishing House. All rights reserved.
Ключевые слова:
Alzheimer's disease; Cognitive impairment; Dementia of the Alzheimer type; Glutamatergic therapy; Memantine; Pathogenetic therapy
memantine; Alzheimer disease; Article; clinical feature; cognitive therapy; genetic screening; laboratory technique; neuroimaging; physical activity; risk factor
Язык текста: Русский
ISSN: 2310-1342
Коберскайа Н. Н.
Koberskaya N. N.
Alzheimer's disease [Болезнь Альцгеймера]
Текст визуальный непосредственный
Неврология, нейропсихиатрия, психосоматика
ИМА-Пресс
Т. 11 С. 52-60
2019
Статья
Alzheimer's disease Cognitive impairment Dementia of the Alzheimer type Glutamatergic therapy Memantine Pathogenetic therapy
memantine Alzheimer disease Article clinical feature cognitive therapy genetic screening laboratory technique neuroimaging physical activity risk factor
Despite progress made in laboratory methods, genetic studies, and modern neuroimaging, the diagnosis of diseases that cause dementia makes difficulties. The review presents an update on the epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis, and treatment of Alzheimer's disease (AD). It discusses the issues of symptomatic and pathogenetic treatments and combination therapy for AD. The efficacy of memantine (akatinol memantine) and the expediency of its use at different stages of the disease in patients with AD are noted. Non-pharmacological treatments for this disease, including physical activity and cognitive training, are considered. © 2019 Ima-Press Publishing House. All rights reserved.